Create Account

One Health helps you track and understand your health simply.

Create Account

One Health helps you track and understand your health simply.

Clonazepam Level (blood)

Drug Monitoring

Clonazepam TDMCZP levelKlonopin level

Review status

Currently under review

Pending specialist review and validation.

What it shows

This test measures the amount of clonazepam in your blood. Clonazepam is a benzodiazepine used to help control seizures and to treat panic disorder. The result shows how much of the medication is circulating and how your body is processing it.

It is a therapeutic drug monitoring test that supports safe and effective dosing. Your sample is collected with a blood draw, often timed just before your next dose so the result reflects a steady baseline.

Why it matters

Keeping clonazepam within an individualized therapeutic window can improve seizure control or reduce panic symptoms while limiting side effects such as sleepiness, confusion, or unsteadiness. The test is often ordered after starting therapy, during dose adjustments, if symptoms persist, or if side effects raise concern for too much medication.

It is also useful when other medicines, liver problems, older age, or pregnancy could change how your body handles the drug. The level can help confirm adherence and guide careful dosing decisions made with your prescriber to balance benefits and safety.

Understanding your results

Your clinician will interpret your level in the context of when the sample was drawn, your dose and timing, other medicines, and how you are feeling. A value lower than the target for you may point to missed doses, rapid metabolism, or interactions that increase drug breakdown. A value higher than expected may reflect accumulation, slower metabolism, or interactions that reduce breakdown.

Do not change your dose on your own. If needed, your clinician may repeat a trough sample, adjust timing, review other medications and supplements, or check liver function. Because clonazepam can add to the effects of alcohol, opioids, and other sedatives, your overall safety plan and symptoms will guide the next steps.

Reference ranges

0.10.3 umol/L
All sexes
0 days – 150 years

Reference intervals vary by laboratory, analyzer, methodology, population, and units. The ranges shown here are for education only. Always interpret your results against the reference interval printed on your own lab report.

Factors that could impact Clonazepam Level (blood)

  • Trough timing

    For consistent interpretation, blood is usually drawn just before your next dose. Samples taken soon after a dose can look higher and may not reflect your steady level.

  • Drug interactions

    Medicines and supplements that affect metabolizing enzymes can change levels. Examples include certain antifungals, macrolide antibiotics, seizure medicines, rifampin, and herbal products like St. John’s wort.

  • Liver function and age

    Clonazepam is processed by the liver. Liver disease and older age can slow clearance, increasing levels and side effects. Your provider may adjust dose and monitoring.

  • Sample type and handling

    Serum or plasma is acceptable, but incorrect tube type, delayed processing, or sample issues can affect results. Proper collection and handling help ensure accuracy.

  • Adherence and formulation

    Missed or irregular doses and changes between tablet types can shift levels. Take doses as prescribed and tell your clinician about any changes in how you take the medicine.

  • Pregnancy and postpartum

    Body changes during pregnancy and after delivery can alter drug handling. Discuss monitoring needs to balance symptom control with maternal and infant safety.

2026

References

  1. McGill University Health Centre. (2006, August 25). Clonazepam (Task CD 695384). Laboratory reference ranges.
  2. Hiemke, C., Bergemann, N., Clement, H. W., Conca, A., Deckert, J., Domschke, K., Eckermann, G., Egberts, K., Gerlach, M., Greiner, C., Gründer, G., Haen, E., Havemann-Reinecke, U., Hefner, G., Helmer, R., Janssen, G., Jaquenoud Eßlen, M., Laux, G., Lutz, U. C., ... Zernig, G. (2018). AGNP consensus guidelines for therapeutic drug monitoring in psychiatry: Update 2017. Pharmacopsychiatry, 51(1-02), 9–62.
  3. U.S. Food and Drug Administration. (2021). Klonopin (clonazepam) prescribing information.